| 07/22/07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 06/22/06 | Notification about results of final buy-back of shares | AQ |
| 30/21/30 | Notification about final share buy-back | AQ |
| 28/21/28 | Correction: Regarding results of a share buy-back offer | AQ |
| 28/21/28 | On substantial participation (4) - specified | AQ |
| 1 day | +7.19% |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 01/01/2026 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 01/01/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
Janis Buks
CHM | Chairman | - | 01/09/2022 |
| Director/Board Member | 63 | 19/06/2021 | |
Vadims Telica
BRD | Director/Board Member | 62 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04/21/04 | Sell | Chief Financial Officer | 97,424 | 0.6917% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.19% | +2.67% | - | - | 15Cr | |
| +0.75% | +1.55% | +6.93% | +83.72% | 4.5TCr | |
| -0.20% | -5.34% | +38.85% | +88.89% | 3.35TCr | |
| +0.44% | -0.66% | -8.69% | +43.35% | 1.17TCr | |
| -0.11% | +1.85% | +12.86% | +117.57% | 1.16TCr | |
| +0.59% | +0.78% | +37.07% | +126.43% | 897.31Cr | |
| +2.40% | +0.42% | +17.89% | +42.70% | 689.2Cr | |
| -1.12% | +0.77% | +40.21% | -17.13% | 655.16Cr | |
| +1.37% | -0.31% | +32.92% | +241.77% | 632.03Cr | |
| +0.51% | -2.46% | -39.66% | -6.34% | 512.35Cr | |
| Average | +1.18% | -0.46% | +15.37% | +80.11% | 1.51TCr | |
| Weighted average by Cap. | +0.42% | -0.96% | +17.59% | +84.26% |
Employees
2,191
Sector
Pharmaceuticals
